acetylgalactosamine has been researched along with Cancer of Pancreas in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kokudo, N; Tang, W; Xu, HL; Zhang, KM; Zhao, X | 1 |
Campbell, RB; Kalra, AV | 2 |
Chung, YS; Ho, JJ; Kim, YS; Sawada, T; Sowa, M | 1 |
Cerny, RL; Fontenot, JD; Gross, ML; Hollingsworth, MA; Johnson, N; Mountjoy, KP; Nishimori, I; Perini, F; Sanderson, SD | 1 |
Chung, YS; Ho, JJ; Kim, YS; Sagabe, T; Sawada, T; Sowa, M; Yoon, WH | 1 |
Burdick, MD; Hayashi, T; Hinoda, Y; Hollingsworth, MA; Imai, K; Satoh, S | 1 |
Ishizuka, I; Kosaki, G; Yamakawa, T; Yamamoto, T | 1 |
8 other study(ies) available for acetylgalactosamine and Cancer of Pancreas
Article | Year |
---|---|
Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
Topics: Acetylgalactosamine; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Benzyl Compounds; Biomarkers, Tumor; Cadherins; Carcinoma, Pancreatic Ductal; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Glycosylation; Humans; Male; Middle Aged; Mucin-1; Neoplasm Invasiveness; Neoplasms, Cystic, Mucinous, and Serous; Pancreatic Neoplasms; Time Factors; Tunicamycin; Vimentin | 2014 |
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours.
Topics: Acetylgalactosamine; Animals; Antineoplastic Agents; Benzyl Compounds; Cell Line, Tumor; Female; Fluorouracil; Glycosylation; Mice; Mucin-1; Pancreatic Neoplasms; Treatment Failure; Xenograft Model Antitumor Assays | 2009 |
Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Topics: Acetylgalactosamine; Antimetabolites, Antineoplastic; Benzyl Compounds; Cell Proliferation; Fluorescent Antibody Technique; Fluorouracil; Glioblastoma; Glycosylation; Humans; Microscopy, Fluorescence; Mucin-1; N-Acetylneuraminic Acid; Neuraminidase; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2007 |
E-selectin binding by pancreatic tumor cells is inhibited by cancer sera.
Topics: Acetylgalactosamine; Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Benzyl Compounds; CA-19-9 Antigen; Cell Adhesion; Cell Adhesion Molecules; E-Selectin; Gangliosides; Humans; Lewis Blood Group Antigens; Mucins; Neuraminidase; Pancreatic Neoplasms; Tumor Cells, Cultured; Tunicamycin | 1994 |
N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Topics: Acetylgalactosamine; Amino Acid Sequence; Glycosylation; Humans; Mass Spectrometry; Molecular Sequence Data; Mucin-1; Mucins; N-Acetylgalactosaminyltransferases; Neoplasm Proteins; Pancreatic Neoplasms; Tumor Cells, Cultured | 1994 |
Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness.
Topics: Acetylgalactosamine; Adenocarcinoma; Benzyl Compounds; Cell Adhesion; Cell Aggregation; Cell Membrane; Collagen; Glycosylation; Humans; Neuraminidase; Pancreatic Neoplasms; Sialic Acids; Tumor Cells, Cultured; Tunicamycin | 1993 |
Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule.
Topics: Acetylgalactosamine; Animals; Benzyl Compounds; Cell Adhesion; Cell Division; Cell Movement; Extracellular Matrix Proteins; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Nude; Mucin-1; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Recombinant Proteins; Sequence Deletion; Transfection; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |
Heterogeneity of carcinoembryonic antigen. II. Monosaccharide composition of concanavalin A-reactive and -nonreactive CEA.
Topics: Acetylgalactosamine; Acetylglucosamine; Binding Sites; Carcinoembryonic Antigen; Chromatography, Affinity; Concanavalin A; Fucose; Galactose; Glucosamine; Humans; Liver Neoplasms; Mannose; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Rectal Neoplasms; Sialic Acids | 1975 |